• Aucun résultat trouvé

Correction to: European guidance for the diagnosis and management of osteoporosis in postmenopausal women

N/A
N/A
Protected

Academic year: 2022

Partager "Correction to: European guidance for the diagnosis and management of osteoporosis in postmenopausal women"

Copied!
2
0
0

Texte intégral

(1)

Article

Reference

Correction to: European guidance for the diagnosis and management of osteoporosis in postmenopausal women

KANIS, J.A., et al. & Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF)

Abstract

The article [European guidance for the diagnosis and management of osteoporosis in postmenopausal women], written by [J. A. Kanis], was originally published Online First without Open Access.

KANIS, J.A., et al . & Committees of Scientific Advisors and National Societies of the

International Osteoporosis Foundation (IOF). Correction to: European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporosis International , 2020, vol. 31, no. 4, p. 801

DOI : 10.1007/s00198-020-05303-5 PMID : 32072205

Available at:

http://archive-ouverte.unige.ch/unige:144127

Disclaimer: layout of this document may differ from the published version.

1 / 1

(2)

CORRECTION

Correction to: European guidance for the diagnosis and management of osteoporosis in postmenopausal women

J.A. Kanis

1,2&

C. Cooper

3,4&

R. Rizzoli

5&

J.-Y. Reginster

6,7&

on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF)

Published online: 18 February 2020

Correction to: Osteoporosis International (2019) 30:3

44

https://doi.org/10.1007/s00198-018-4704-5

The article [European guidance for the diagnosis and management of osteoporosis in postmenopausal women], written by [J. A. Kanis], was originally published Online First without Open Access. After publication in volume [#], issue [#], page [#-#] the author decided to opt for Open Choice and to make the article an Open Access publication. Therefore, the copyright of the arti- cle has been changed to © The Author(s) [2018] and the article is forthwith distributed under the terms of a Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/

licenses/by-nc/4.0/), which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a

link to the Creative Commons license, and indicate if changes were made.

The original article has been corrected.

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduc- tion in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the ma- terial. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://

creativecommons.org/licenses/by-nc/4.0/.

>

The online version of the original article can be found athttps://doi.org/10.

1007/s00198-018-4704-5

* J.A. Kanis

w.j.Pontefract@shef.ac.uk

1 Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, UK

2 Mary McKillop Health Institute, Australian Catholic University, Melbourne, Australia

3 MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK

4 NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, UK

5 University Hospitals and Faculty of Medicine of Geneva, Geneva, Switzerland

6 Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium

7 Prince Mutaib Chair for Biomarkers of Osteoporosis, Biochemistry Department, College of Science, King Saud University,

Riyadh, Kingdom of Saudi Arabia Osteoporosis International(2020) 31:801

https://doi.org/10.1007/s00198-020-05303-5

© The Author(s) 2020

#

Références

Documents relatifs

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adap- tation, distribution and reproduction in

Because air mass factors (AMFs) vary significantly with wavelength as a result of significant vari- ation of O 3 absorption, the wavelength- and surface-albedo- dependent AMF, which

(10) include a smoothing error component and should not be used to calculate the error budget because the data user might not be aware of related problems and might, when

Here we report (1) a systematic proteomic study of the CSF with a thorough characterization of the synaptic composition (discovery), (2) development of Tier 2 SRM assays for a set

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any